FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Insulin Glargine Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Other

Expand all

Sanofi-Aventis U.S. LLC (New 05/24/2024)

Company Contact Information:
800-633-1610 Option 7

Presentation	Posting Date	Related Information
Insulin Glargine Solostar, Injection, 100 [iU]/mL (NDC 0955-1728-05)	05/24/2024	Sanofi has discontinued this product due to a business decision.
Insulin glargine, Injection, 100 [iU]/mL (NDC 0955-1729-01)	05/24/2024	Sanofi has discontinued this product due to a business decision.